Laurion Capital Management LP Stoke Therapeutics, Inc. Transaction History

Laurion Capital Management LP

  • $7.27 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024
BUY
$4.12 - $14.17 $412,000 - $1.42 Million
100,000 New
100,000 $1.35 Million
Q3 2019

Nov 13, 2019
SELL
$20.53 - $37.72 $513,250 - $943,000
-25,000 Closed
0 $0
Q2 2019

Aug 13, 2019
BUY
$25.53 - $29.17 $638,250 - $729,250
25,000 New
25,000 $729,000

Others Institutions Holding STOK

# of Institutions
125
Shares Held
57.6M
Call Options Held
9.3K
Put Options Held
35.2K
View Full List

About Stoke Therapeutics, Inc.

STOK Quotes by TradingView
  • Ticker STOK
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 39,419,300
  • Market Cap $367M
  • Description
  • Stoke Therapeutics, Inc., an early-stage biopharmaceutical company, develops novel antisense oligonucleotide (ASO) medicines to treat the underlying causes of severe genetic diseases in the United States. The company utilizes its proprietary Targeted Augmentation of Nuclear Gene Output to design ASOs to precisely upregulate protein expression. I...
More about STOK
Track This Portfolio

Track Laurion Capital Management LP Portfolio

Follow Laurion Capital Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Laurion Capital Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Laurion Capital Management LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email